Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Thérèse Aurran Schleinitz"'
Autor:
Anne Quinquenel, Thérèse Aurran-Schleinitz, Aline Clavert, Florence Cymbalista, Caroline Dartigeas, Frédéric Davi, Sophie de Guibert, Alain Delmer, Marie-Sarah Dilhuydy, Pierre Feugier, Luc-Matthieu Fornecker, David Ghez, Romain Guieze, Kamel Laribi, Véronique Leblond, Stéphane Leprêtre, Rémi Letestu, Vincent Lévy, Florence Nguyen-Khac, Anne-Sophie Michallet, Cécile Tomowiak, Olivier Tournilhac, Loïc Ysebaert, Xavier Troussard, on the behalf of the FILO-LLC Group
Publikováno v:
HemaSphere, Vol 4, Iss 5, p e473 (2020)
Abstract. As a result of significant recent developments, the management of patients with chronic lymphocytic leukemia (CLL) is changing, and new therapeutic options will continue to emerge in the near future. The recommendations of the French Innova
Externí odkaz:
https://doaj.org/article/09eb754c87c6431b99b76fa1236289e3
Autor:
Robin Noel, Christophe Zemmour, Catalina Montes de Oca, Nawel Belmecheri, Thérèse Aurran-Schleinitz, Diane Coso, Leonor Lopez Almeida, Lénaïg Mescam, Norbert Vey, Jean Sébastien Bladé, Borhane Slama, Reda Bouabdallah, Jean-Marc Schiano de Colella
Publikováno v:
Hematology. 28
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d021eb9fb3db087f3635efa56f69e5b6
https://doi.org/10.1080/16078454.2023.2207948
https://doi.org/10.1080/16078454.2023.2207948
Autor:
Anne-Sophie Michallet, Rémi Letestu, Magali Le Garff-Tavernier, Lydia Campos, Michel Ticchioni, Marie-Sarah Dilhuydy, Stephane MORISSET, Valerie Rouille, Beatrice Mahe, Kamel Laribi, Bruno Villemagne, Emmanuelle France Ferrant, Olivier Tournilhac, Alain Jacques Delmer, Lysiane Molina, Veronique Leblond, Cécile TOMOWIAK, Sophie De Guibert, Frederique Orsini Piocelle, Anne Banos, Philippe Carassou, Guillaume Cartron, Luc-Matthieu Fornecker, Loïc Ysebaert, Caroline Dartigeas, Malgorzata Truchan-Graczyk, Jean-Pierre Vilque, Thérèse Aurran Schleinitz, Florence Cymbalista, Stéphane Leprêtre, Vincent Lévy, Florence Nguyen-Khac, Pierre Feugier
Publikováno v:
Blood Advances.
In previously untreated, medically fit patients with chronic lymphocytic leukemia, research is focused on developing fixed-duration strategies to improve long-term outcomes whilst sparing patients from serious toxicities. The ICLL-07 trial evaluated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8291053de23de4e66ca99d7c20098031
https://doi.org/10.1182/bloodadvances.2022009594
https://doi.org/10.1182/bloodadvances.2022009594
Autor:
Romain Guieze, Loic Ysebaert, Damien Roos-Weil, Luc-Matthieu Fornecker, Emmanuelle Ferrant, Lysiane Molina, Thérèse Aurran-Schleinitz, Aline Clavert, Sophie de Guibert, Anne-Sophie Michallet, Alain Saad, Bernard Drenou, Philippe Quittet, Benedicte Hivert, Kamel Laribi, Julie Gay, Julien Broséus, Valérie Rouille, David Schwartz, Bruno Pereira, Alain Delmer, Pierre Feugier
Publikováno v:
Blood. 140:6631-6632
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b5112becd1188cb26155a8b28ed3abe
https://doi.org/10.1182/blood-2022-159695
https://doi.org/10.1182/blood-2022-159695
Autor:
Franck Morschhauser, Laure Lebras, Paul Coppo, Fabien Subtil, Bénédicte Deau-Fischer, Lucile Bussot, Charles Bescond, Thérèse Aurran-Schleinitz, Hervé Ghesquières, Simon Favre, Amira Marouf, Bénédicte Burlet, Cédric Rossi, Sandrine Malot, Xavier Roussel, Emmanuel Gyan, Sylvain Carras, Laurianne Drieu La Rochelle, Marianne Schwarz, Anne-Sophie Michallet, Roza Chin, Adrien Daniel, Romain Guieze, Thierry Lamy De La Chapelle, Pierre Sesques, Carolyne Croizier, Marie-Charlotte Laude, Krimo Bouabdallah, Adrien Chauchet
Publikováno v:
American Journal of Hematology
American Journal of Hematology, 2020, 96 (3), pp.302-311. ⟨10.1002/ajh.26068⟩
American Journal of Hematology, 2020, 96 (3), pp.302-311. ⟨10.1002/ajh.26068⟩
International audience; Historically, double or triple hit lymphoma (DHL and THL) have poor outcomes with conventional chemotherapy, but there is currently no guideline. We report the French experience in managing DHL and THL in first line using coll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f275d0ab01d3b4f66a8e8668641935a2
https://www.hal.inserm.fr/inserm-03823000
https://www.hal.inserm.fr/inserm-03823000
Autor:
Priti Patel, Dih-Yih Chen, Olivier Tournilhac, Thérèse Aurran-Schleinitz, Raquel Izumi, Efstathios Kastritis, Sheeba K. Thomas, Ahmed Hamdy, Monique C. Minnema, Francesco Forconi, Helen McCarthy, Richard R. Furman, Pier Luigi Zinzani, Diana Mittag, Shirley D'Sa, Daniel Reif Greenwald, Marie José Kersten, Simon Rule, Sunil Iyengar, Harriet S. Walter, Jaimal Kothari, Roger G. Owen, Sun Ku Lee, Melanie M. Frigault, Helen Wei, Bruce D. Cheson
Publikováno v:
The Lancet Haematology
The Lancet Haematology, Elsevier, 2020, 7 (2), pp.e112-e121. ⟨10.1016/S2352-3026(19)30210-8⟩
The Lancet Haematology, 2020, 7 (2), pp.e112-e121. ⟨10.1016/S2352-3026(19)30210-8⟩
Lancet haematology, 7(2), e112. Lancet Publishing Group
Lancet. Haematology, 7(2), e112-e121. Lancet Publishing Group
The Lancet Haematology, Elsevier, 2020, 7 (2), pp.e112-e121. ⟨10.1016/S2352-3026(19)30210-8⟩
The Lancet Haematology, 2020, 7 (2), pp.e112-e121. ⟨10.1016/S2352-3026(19)30210-8⟩
Lancet haematology, 7(2), e112. Lancet Publishing Group
Lancet. Haematology, 7(2), e112-e121. Lancet Publishing Group
Summary Background Chemoimmunotherapy is typically the standard of care for patients with Waldenstrom macroglobulinemia; however, infectious and hematologic toxic effects are problematic. Acalabrutinib is a selective, potent Bruton tyrosine-kinase in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b08811b4c09666e7e36fe58d1ae7b6a
https://hal.uca.fr/hal-02885323
https://hal.uca.fr/hal-02885323
Autor:
Sophie de Guibert, Thérèse Aurran-Schleinitz, Marie C. Béné, Hervé Maisonneuve, Anne-Sophie Michallet, Marie-Sarah Dilhuydy, Christian Berthou, Florence Cymbalista, Olivier Tournilhac, Stéphane Leprêtre, Eric Van Den Neste, Philippe Rodon, Kamel Laribi, Véronique Leblond, Florence Nguyen-Khac, Rémi Letestu, Pierre Feugier, Caroline Dartigeas, Jean-Pierre Vilque, Alain Delmer, Philippe Colombat, Julie Léger, Beatrice Mahe, Vincent Levy, Roselyne Delepine
Publikováno v:
The Lancet Haematology
The Lancet Haematology, 2018, 5 (2), pp.e82-e94. ⟨10.1016/S2352-3026(17)30235-1⟩
The Lancet Haematology, Elsevier, 2018, 5 (2), pp.e82-e94. ⟨10.1016/S2352-3026(17)30235-1⟩
The Lancet Haematology, 2018, 5 (2), pp.e82-e94. ⟨10.1016/S2352-3026(17)30235-1⟩
The Lancet Haematology, Elsevier, 2018, 5 (2), pp.e82-e94. ⟨10.1016/S2352-3026(17)30235-1⟩
Summary Background Most patients with chronic lymphocytic leukaemia relapse after initial therapy combining chemotherapy with rituximab. We assessed the efficacy and safety of rituximab maintenance treatment versus observation for elderly patients in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc31e77e3ff43b57d34311d5a749b4b7
https://doi.org/10.1016/s2352-3026(17)30235-1
https://doi.org/10.1016/s2352-3026(17)30235-1
Autor:
Jean-Robert Delpero, Vincent Bréjard, Léna Lounis, Thérèse Aurran-Schleinitz, Olivier Turrini
Publikováno v:
Pancreas. 48(4)
This review aimed to inventory and analyze previous studies regarding quality of life (QoL) and psychological outcomes in relation to pancreatectomy. PubMed and PsycInfo databases were reviewed using the Preferred Reporting Items for Systematic revie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5a8e5793c96d3e4cf7f21f894511016
https://pubmed.ncbi.nlm.nih.gov/30973462
https://pubmed.ncbi.nlm.nih.gov/30973462
Autor:
Claire Albrecht, Caroline Dartigeas, Olivier Tournilhac, Anne-Sophie Michallet, Jehan Dupuis, Pierre Sinet, Pierre Feugier, Loic Ysebaert, Thérèse Aurran-Schleinitz, Florence Cymbalista, Marie-Sarah Dilhuydy
Publikováno v:
American Journal of Hematology. 92:E166-E168
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::edffaac1844c05785ee58c2ceac34fdf
https://doi.org/10.1002/ajh.24773
https://doi.org/10.1002/ajh.24773
Autor:
Stephan Stilgenbauer, Jean-François Rossi, Barbara Eichhorst, Petra Blum, Fabian Lang, Loic Ysebaert, Uta Ursula Kress, Fritz Offner, Thorsten Zenz, Eric Van Den Neste, Ute von Wangenheim, Thérèse Aurran Schleinitz, Wilfried Schroyens
Publikováno v:
Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab6982e244b7bffc703a5fa3b5622273
https://hdl.handle.net/10067/1637500151162165141
https://hdl.handle.net/10067/1637500151162165141